Seth Ettenberg, Chief Scientific Officer at Unum Therapeutics Inc. (UMRX), sold 11,485 shares at $7.00 ($80K) on 2018-11-26, disclosed to the SEC on 2018-11-26.
Open-market sale of $80k UMRX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| UMRX | SELL | 2018-12-28 | $47K | — | Filing → |
| UMRX | SELL | 2018-10-29 | $194K | — | Filing → |
| UMRX | SELL | 2018-09-26 | $286K | — | Filing → |